Europe Cell and Gene Therapy Manufacturing QC Market Report 2023-2033: Increasing Demand for Cell and Gene Therapies Spurs Growth
DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Europe Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The Europe cell and gene therapy manufacturing Quality Control (QC) market is expec
Ball Corporation Announces Early Results of Cash Tender Offers for Certain Outstanding Debt Securities
WESTMINSTER, Colo., Feb. 28, 2024 /PRNewswire/ — Ball Corporation (“Ball”) (NYSE: BALL) announced today the early results of its previously announced offers to purchase for cash (i) any and all of the $1,000,000,000 aggregate principal amount of its outstanding 5.25% Senior Notes d
Genomma Lab’s ESG Rating Upgraded to A
Reflects Third Consecutive Rating Improvement in Four Years MEXICO CITY, Feb. 28, 2024 /PRNewswire/ — Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), one of the leading pharmaceutical and personal care product companies in Mexic
Talos Energy Announces Fourth Quarter and Full Year 2023 Operational and Financial Results
HOUSTON, Feb. 28, 2024 /PRNewswire/ — Talos Energy Inc. (“Talos” or the “Company”) (NYSE: TALO) today announced its operational and financial results for fiscal quarter and full year ended December 31, 2023. Talos also announced its year-end 2023 reserves estimates and
Europe Sustainable Tire Materials Market Analysis 2023-2024 and 2032: Burgeoning Opportunities in the Utilization of Advanced Recycling Techniques within the Tire Circular Economy Model
DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Europe Sustainable Tire Materials Market: Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The Europe sustainable tire materials market (excluding U.K.) is projected to reach $358.5 mill
Every Cure to Receive $48.3M from ARPA-H to Develop AI-Driven Platform to Revolutionize Future of Drug Development and Repurposing
ARPA-H contract will supercharge Every Cure’s work to identify existing medicines that can be repurposed to treat currently untreated diseases. Initial progress utilizing a pilot version of the AI platform and stakeholder engagement has led to the identification of potential treatments for sic
Media Advisory – Prime Minister’s itinerary for Thursday, February 29, 2024
OTTAWA, ON, Feb. 28, 2024 /CNW/ – Note: All times local Thunder Bay (Ontario) 11:45 a.m. The Prime Minister will make a housing announcement. The Minister of Indigenous Services and Minister responsible for the Federal Economic Development Agency for Northern Ontario, Patty Hajdu, will also be
Sprinklr Set to Join S&P SmallCap 600
NEW YORK, Feb. 28, 2024 /PRNewswire/ — Sprinklr Inc. (NYSE:CXM) will replace Veradigm Inc. (NASD:MDRX) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, March 4. Veradigm will be suspended from the Nasdaq Stock Market on February 29 due to non-compliance with NAS
Empire Life reports fourth quarter results
Q4 2023 highlights (compared to restated Q4 2022) Common shareholders’ net income of $111 million (compared to restated net income of $5 million)Earnings per share (basic and diluted) of $112.15 (compared to restated $5.32) 2023 highlights (compared to restated 2022) Common shareholders’
